About Us
Biotechnology company founded by researchers
ScandiBio Therapeutics is a biotechnology company founded by researchers from the KTH Royal Institute of Technology, Karolinska Institutet and Sahlgrenska Academy in Sweden and Kings College, UK. The science originates from research conducted at the Science for Life Laboratory in Stockholm (Dr Adil Mardinoglu and Professor Mathias Uhlen) together with researchers at the Sahlgrenska Academy in Göteborg (Professor Jan Boren).
Meet The Team
Senior Management
Dr Olof Nord
CEO
Dr Adil Marinoglu
CSO
Johan Järte, MD
CMO
Dr Marianne Hansson
CFO
The Board
Prof Mathias Uhlen
Chairman of the Board and co-founder
Prof Jan Boren
Co-founder, expert in lipid metabolism and liver disorders, chair of medicine department at Sahlgrenska hospital, Gothenburg
Prof Henrik Zetterberg
International authority in the field of Alzheimer’s disease
Dr Adil Marinoglu
Co-founder and board member
Elin Almstedt
Representing Navigare Ventures
